Performant Healthcare, Inc. (Nasdaq: PHLT) (“Performant”), a leading provider of technology-enabled payment integrity, eligibility, and related analytics services, announced today that it will par...
PLANTATION, Fla.: Performant Healthcare, Inc. (Nasdaq: PHLT) (“Performant”), a leading provider of technology-enabled payment integrity, eligibility, and related analytics services, announced today that it will participate in the 10th Annual Oppenheimer Emerging Growth Conference on Wednesday, February 26th.
Performant’s Chief Financial Officer, Rohit Ramchandani, will participate in one-on-one meetings to discuss key topics, including the potential company’s impact under the new administration and developments in DOGE. These meetings will be held virtually on February 26th.
To schedule a meeting, please contact Performant or your Oppenheimer representative.
ABOUT PERFORMANT
Performant supports healthcare payers in identifying, preventing, and recovering waste and improper payments by leveraging advanced technology, analytics and proprietary data assets. Performant works with leading national and regional healthcare payers to provide eligibility-based, also known as coordination-of-benefits (COB) services, as well as claims-based services, which includes the audit and identification of improperly paid claims. Performant is a leading provider of these services in both government and commercial healthcare markets. Performant also provides advanced reporting capabilities, support services, customer care, and stakeholder training programs designed to mitigate future instances of improper payments.
To learn more about Performant, please visit https://www.performanthealthcare.com
Fonte: Business Wire
Alaa Abdul Nabi, Vice President, Sales International at RSA presents the innovations the vendor brings to Cybertech as part of a passwordless vision for…
G11 Media's SecurityOpenLab magazine rewards excellence in cybersecurity: the best vendors based on user votes
Always keeping an European perspective, Austria has developed a thriving AI ecosystem that now can attract talents and companies from other countries
Successfully completing a Proof of Concept implementation in Athens, the two Italian companies prove that QKD can be easily implemented also in pre-existing…
BostonGene, a leader in AI-powered solutions for drug discovery and development, today announced that six abstracts have been accepted at the 2025 ASCO…
Resecurity, a U.S.-based leader in cyber threat intelligence and risk management solutions, is proud to announce its participation in DSEI Japan 2025,…
Generational Group, a leading mergers and acquisitions advisory firm for privately held businesses, is pleased to announce the sale of Elarasys Worldwide,…
LICT Corporation (“LICT” or the “Company”; OTC Pink®: LICT) reports financial results for the quarter ended March 31, 2025. Total revenues for the first…